Aquestive Therapeutics leverages its PharmFilm technology to develop innovative oral drug delivery systems. Find out why I'm neutral on AQST stock.

Q4 2024 Earnings Call Transcript March 20, 2025 ARS Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.52, ...

This past week, my Motion 518: Expanding Availability of Epinephrine Auto-Injectors was successfully passed in Alberta’s ...

Cash Position & Operating Runway: As of December 31, 2024, ARS Pharma had cash, cash equivalents, and short-term investments ...

An adrenaline rush is a colloquial expression about the feeling of exhilaration and heightened energy that is brought on by ...

The US Food and Drug Administration (FDA) has approved Neffy, a nasal spray for treating severe allergic reactions in ...

Whether finding new treatments for schizophrenia or first-time ways to tackle bladder cancer, these companies are finding ...

Lawmakers took a step Wednesday to cap the out-of-pocket cost for epinephrine injectors and ensure Nebraska schools and licensed child care programs have policies to respond to allergic reactions.

Schools should maintain a minimum of one epinephrine auto-injector for emergency use. Schools should work with local pharmacies to determine the appropriate type and number of epinephrine ...

The global epinephrine auto-injector market is set for steady expansion, driven by the increasing prevalence of severe allergies worldwide. According to market projections, global sales of epinephrine ...

The only treatment to quell the allergic reaction is epinephrine, which historically has been administered through shots or auto-injectors, such as the EpiPen. In August, ARS Pharmaceuticals ...